Coloplast A/S (OTCMKTS:CLPBY) Issues Quarterly Earnings Results

Coloplast A/S (OTCMKTS:CLPBY) posted its quarterly earnings data on Tuesday. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10, Zacks reports. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%.

Coloplast A/S Stock Performance

Coloplast A/S stock opened at $6.58 on Tuesday. The stock has a 50-day simple moving average of $6.23 and a 200 day simple moving average of $6.68. The stock has a market capitalization of $14.83 billion, a price-to-earnings ratio of 47.00, a P/E/G ratio of 2.12 and a beta of 0.13. The company has a quick ratio of 1.09, a current ratio of 1.75 and a debt-to-equity ratio of 1.66. Coloplast A/S has a 12-month low of $5.64 and a 12-month high of $10.03.

Analyst Upgrades and Downgrades

Separately, Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.